SCHEMBL30006224

SCHEMBL30006224

Cc1nnc2n1-c1c(c(F)cc(Br)c1C(F)F)NC2(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21624306 1.00 — —
SCHEMBL21624323 0.86 — —
SCHEMBL30005652 0.86 — —
SCHEMBL30005469 0.82 MEN1 (0.33) —
SCHEMBL21624359 0.82 — —
SCHEMBL21624311 0.82 CYP11B1 (0.33) —
SCHEMBL21624293 0.82 MEN1 (0.33) —
SCHEMBL30005792 0.82 CYP11B1 (0.33) —
SCHEMBL21624295 0.81 CYP11B2 (0.31) —
SCHEMBL21636850 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4090660-A1 QUINOXALINE DERIVATIVES Grünenthal GmbH (DE) 2022-11-23 — — EP disclosed
Send feedback